Car T Cell Therapy Market Scope And Analysis

  • Report Code : TIPRE00029935
  • Category : Biotechnology
  • No. of Pages : 150
Buy Now

CAR-T Cell Therapy Market Analysis, Size, and Growth (2021-2022)

Buy Now

CAR-T Cell Therapy Market Report CAR-T Cell Therapy Market Size and Share CAR-T Cell Therapy Market Scope and Analysis

CAR-T Cell Therapy Market Report Scope

Report Attribute Details
Market size in 2022 US$ 2.79 Billion
Market Size by 2030 US$ 10.13 Billion
Global CAGR (2022 - 2030) 17.5%
Historical Data 2020-2022
Forecast period 2022-2030
Segments Covered By Targeted Antigen
  • CD19 and BCMA
By Indication
  • Lymphomas
  • Leukemia
  • Multiple Myeloma
By End User
  • Hospitals and Specialty Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bristol Myers Squibb Company
  • Novartis AG
  • Gilead Sciences Inc
  • Johnson Johnson Services Inc
  • CARsgenTherapeutics Co Ltd
  • Aurora Biopharma
  • Legend Biotech
  • Pfizer Inc
  • bluebird bio Inc

    • Competitive Landscape and Key Companies:

    Bristol-Myers Squibb Company; Novartis AG; Gilead Sciences, Inc.; Johnson & Johnson Services, Inc.; CARsgenTherapeutics Co., Ltd; Aurora Biopharma; Legend Biotech; Pfizer Inc.; bluebird bio, Inc.; Mustang Bio; Sorrento Therapeutics, Inc.; and Fate Therapeutics are among the prominent companies profiled in the CAR-T cell therapy market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide.